Eisai Global Executive and Leadership Team

Tatsuyuki Yasuno, the Chairman & Chief Executive Officer & Eisai Inc Region President (Americas) at Eisai Global, directs the overarching corporate strategy and regional operations across the Americas. Yasuno architects the human health care philosophy, ensuring pharmaceutical manufacturing processes align with patient needs. By overseeing the integration of research and development initiatives, the Chairman & Chief Executive Officer & Eisai Inc Region President (Americas) maintains a competitive edge in the global market. This leadership role involves constant collaboration with the Board to drive long-term growth and operational excellence. Tatsuyuki Yasuno monitors market trends to refine the company's business-to-consumer approach, securing a robust presence in the United States. Through strategic oversight of regional expansion, the executive ensures that pharmaceutical development remains responsive to evolving healthcare demands, ultimately strengthening the company's position as a leader in the pharmaceutical sector.

Michael Montaigne, the President, Eisai Machinery (USA) at Eisai Global, oversees the specialized manufacturing equipment division focused on pharmaceutical production efficiency. Montaigne directs the development and deployment of high-precision machinery that supports the company's business-to-business operations. By managing the North American supply chain for industrial hardware, the President, Eisai Machinery (USA) ensures that production facilities maintain optimal output levels. This leadership role involves aligning equipment capabilities with the rigorous quality standards required for pharmaceutical manufacturing. Michael Montaigne monitors market demand for advanced production tools, driving innovation in automated systems that reduce waste and improve safety. Through strategic partnerships with internal research teams, the executive facilitates the transition from laboratory-scale development to large-scale manufacturing. By focusing on technical reliability and operational speed, the President, Eisai Machinery (USA) contributes directly to the company's ability to deliver essential medicines to patients worldwide.

Hiroyuki Murayama, the President (Japan) & Promotion Department Manager, Product Strategy at Eisai Global, leads the commercialization efforts and product positioning within the Japanese market. Murayama architects comprehensive promotion strategies that highlight the human health care approach to healthcare providers and patients. By overseeing the product strategy department, the President (Japan) & Promotion Department Manager, Product Strategy ensures that new pharmaceutical offerings meet specific therapeutic needs. This role involves coordinating with regional sales teams to maximize market penetration and brand awareness. Hiroyuki Murayama monitors competitive landscapes to adjust promotional tactics, ensuring that the company's value proposition remains clear and impactful. Through the alignment of marketing campaigns with clinical research findings, the executive drives revenue growth and strengthens the company's reputation. By fostering strong relationships with local healthcare stakeholders, the President (Japan) & Promotion Department Manager, Product Strategy secures a dominant market position for key therapeutic products.

Kazuhiko Tamura, the Vice President and President, Eisai Demand Chain Systems at Eisai Global, manages the end-to-end logistics and supply chain network that delivers medicines to global markets. Tamura architects efficient demand forecasting models that align production schedules with real-time market requirements. By overseeing the distribution infrastructure, the Vice President and President, Eisai Demand Chain Systems ensures that pharmaceutical products reach patients across Asia Pacific and the Middle East without delay. This leadership role involves optimizing inventory management to reduce costs while maintaining high service levels. Kazuhiko Tamura drives the implementation of integrated systems that connect manufacturing output with regional demand, minimizing supply chain disruptions. Through constant analysis of global logistics trends, the executive improves the speed and reliability of the company's delivery network. By focusing on operational efficiency, the Vice President and President, Eisai Demand Chain Systems supports the company's mission to provide consistent access to life-saving treatments.

Toshimitsu Uenaka, the President, Epochal Precision Anti-Cancer Therapeutics at Eisai Global, leads the specialized research and development unit dedicated to oncology. Uenaka architects the scientific roadmap for developing targeted anti-cancer medicines that align with the company's human health care philosophy. By overseeing clinical trials and laboratory research, the President, Epochal Precision Anti-Cancer Therapeutics ensures that new therapies address critical unmet needs in oncology. This role involves collaborating with global research partners to accelerate the discovery of precision treatments. Toshimitsu Uenaka monitors the progress of the drug pipeline, making strategic decisions to prioritize high-potential therapeutic candidates. Through the integration of advanced genomic research, the executive drives innovation in personalized medicine. By focusing on scientific rigor and patient outcomes, the President, Epochal Precision Anti-Cancer Therapeutics plays a central role in expanding the company's portfolio of life-extending treatments and maintaining a strong presence in the competitive oncology sector.

Yanhui Feng, the President & General Manager (Eci) at Eisai Global, directs the operational activities and strategic growth within the Chinese market. Feng architects localized business strategies that adapt the company's global pharmaceutical model to the specific regulatory and healthcare environment in China. By overseeing the general management of regional operations, the President & General Manager (Eci) ensures that the company's human health care approach resonates with local patients and providers. This role involves coordinating with cross-functional teams to drive product launches and market expansion. Yanhui Feng monitors regional economic trends to optimize resource allocation and improve operational performance. Through the development of strong local partnerships, the executive strengthens the company's footprint in the Asia Pacific region. By focusing on sustainable growth and regulatory compliance, the President & General Manager (Eci) contributes to the company's overall success in delivering high-quality pharmaceutical solutions to a diverse and growing patient population.

Makoto Hoketsu, the Vice President & Chief Information Officer at Eisai Global, manages the digital infrastructure and data security frameworks supporting global pharmaceutical operations. Hoketsu architects scalable technology solutions that enhance research efficiency and streamline manufacturing workflows. By implementing advanced analytics, the Vice President & Chief Information Officer optimizes the flow of information across international regions, including Japan and Europe. This role involves coordinating with other C-suite leaders to ensure digital transformation initiatives support the broader human health care mission. Makoto Hoketsu drives the adoption of secure, cloud-based systems to protect sensitive patient data and proprietary research findings. Through the modernization of internal communication platforms, the executive improves cross-departmental collaboration, ensuring that technological capabilities remain aligned with the company's commitment to patient-centered healthcare solutions and long-term operational stability in a complex, data-driven industry.